SNPMiner Trials by Shray Alag


SNPMiner SNPMiner Trials (Home Page)


Report for Clinical Trial NCT03523104

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

The Chinese Parkinson's Disease With LRRK2 Variants Registry

The purpose of the Chinese PD-LRRK2 Registry(CPD-LRRK2R) is to develop a database of patients of Parkinson's disease with leucine-rich repeat kinase 2 (LRRK2) gene variants in mainland China.

NCT03523104 Parkinson Disease
MeSH:Parkinson Disease


Primary Outcomes

Description: Establish the database of Parkinson's disease with LRRK2 variants in mainland China.

Measure: Database of Parkinson's disease with LRRK2 variants

Time: 10 years

Description: Characterize the clinical feature in patients of Parkinson's disease with LRRK2 variants

Measure: Clinical feature

Time: 10 years

Time Perspective: Prospective

Cohort


There are 2 SNPs

SNPs


1 G2385R

However, some polymorphisms of LRRK2 such as G2385R and R1628P can also affect the risk of developing PD. --- G2385R ---


2 R1628P

However, some polymorphisms of LRRK2 such as G2385R and R1628P can also affect the risk of developing PD. --- G2385R --- --- R1628P ---



HPO Nodes